The purine nucleosides adenosine and guanosine delay axonal degeneration in vitro

Journal of Neurochemistry

Volumn 109, Issue 2, 2009, Pages 595-602

  Press, Craig ^b   Milbrandt, Jeffrey ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Axonal degeneration; Guanosine; Purine nucleosides; Wallerian degeneration

Indexed keywords

ADENOSINE; GUANOSINE; INOSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN PROTECTION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE INJURY; NONHUMAN; PRESERVATION; PRIORITY JOURNAL; SPINAL GANGLION;

ADENOSINE; ANIMALS; AXONS; CELLS, CULTURED; GANGLIA, SPINAL; GUANOSINE; MICE; NERVE DEGENERATION; PURINE NUCLEOSIDES; WALLERIAN DEGENERATION;

MUS; WALLERIA;

EID: 62649138640     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06002.x     Document Type: Article

References (43)

1. Araki T., Sasaki Y. Milbrandt J. (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010 1013.
2. Benowitz L. I., Jing Y., Tabibiazar R., Jo S. A., Petrausch B., Stuermer C. A., Rosenberg P. A. Irwin N. (1998) Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J. Biol. Chem. 273, 29626 29634.
3. Berger F., Lau C., Dahlmann M. Ziegler M. (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem. 280, 36334 36341.
4. Bocklinger K., Tomaselli B., Heftberger V., Podhraski V., Bandtlow C. Baier-Bitterlich G. (2004) Purine nucleosides support the neurite outgrowth of primary rat cerebellar granule cells after hypoxia. Eur. J. Cell Biol. 83, 51 54.
5. Chang R., Algird A., Bau C., Rathbone M. P. Jiang S. (2008) Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci. Lett. 431, 101 105.
6. Chen Y., Stevens B., Chang J., Milbrandt J., Barres B. A. Hell J. W. (2008) NS21: re-defined and modified supplement B27 for neuronal cultures. J. Neurosci. Methods 171, 239 247.
7. Coleman M. (2005) Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6, 889 898.
8. Coleman M. P. Perry V. H. (2002) Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25, 532 537.
9. Conforti L., Tarlton A., Mack T. G., Mi W., Buckmaster E. A., Wagner D., Perry V. H. Coleman M. P. (2000) A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc. Natl Acad. Sci. USA 97, 11377 11382.
10. Conforti L., Fang G., Beirowski B. et al. (2006) NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ. 14, 116 127.
11. Cunha R. A. (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38, 107 125.
12. Deckwerth T. L. Johnson E. M. Jr (1994) Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev. Biol. 165, 63 72.
13. Ferri A., Sanes J. R., Coleman M. P., Cunningham J. M. Kato A. C. (2003) Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13, 669 673.
14. Fredholm B. B., AP I. J., Jacobson K. A., Klotz K. N. Linden J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527 552.
15. Gillingwater T. H., Ingham C. A., Parry K. E., Wright A. K., Haley J. E., Wishart T. M., Arbuthnott G. W. Ribchester R. R. (2006) Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. Brain 129, 1546 1556.
16. Hasbani D. M. O'Malley K L. (2006) Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp. Neurol. 202, 93 99.
17. Irwin N., Li Y. M., O'Toole J. E. Benowitz L. I. (2006) Mst3b, a purine-sensitive Ste20-like protein kinase, regulates axon outgrowth. Proc. Natl Acad. Sci. USA 103, 18320 18325.
18. Jiang S., Bendjelloul F., Ballerini P., D'Alimonte I., Nargi E., Jiang C., Huang X. Rathbone M. P. (2007) Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury. Purinergic signal. 3, 411 421.
19. Kaneko S., Wang J., Kaneko M., Yiu G., Hurrell J. M., Chitnis T., Khoury S. J. He Z. (2006) Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci. 26, 9794 9804.
20. Kitagawa H., Mori A., Shimada J., Mitsumoto Y. Kikuchi T. (2002) Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats. Neurol. Res. 24, 317 323.
21. Latini S. Pedata F. (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463 484.
22. Lau Y. S. Mouradian M. M. (1993) Protection against acute MPTP-induced dopamine depletion in mice by adenosine A1 agonist. J. Neurochem. 60, 768 771.
23. Lerman B. B. Belardinelli L. (1991) Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation 83, 1499 1509.
24. Lunn E. R., Perry V. H., Brown M. C., Rosen H. Gordon S. (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1, 27 33.
25. Mi W., Beirowski B., Gillingwater T. H. et al. (2005) The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 128, 405 416.
26. de Oliveira D. L., Horn J. F., Rodrigues J. M., Frizzo M. E., Moriguchi E., Souza D. O. Wofchuk S. (2004) Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine. Brain Res. 1018, 48 54.
27. Pedata F., Corsi C., Melani A., Bordoni F. Latini S. (2001) Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann. NY Acad. Sci. 939, 74 84.
28. Pierri M., Vaudano E., Sager T. Englund U. (2005) KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse. Neuropharmacology 48, 517 524.
29. Podgorska M., Kocbuch K. Pawelczyk T. (2005) Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim. Pol. 52, 749 758.
30. Press C. Milbrandt J. (2008) Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J. Neurosci. 28, 4861 4871.
31. Raff M. C., Whitmore A. V. Finn J. T. (2002) Axonal self-destruction and neurodegeneration. Science 296, 868 871.
32. Rathbone M. P., Middlemiss P. J., Gysbers J. W., Andrew C., Herman M. A., Reed J. K., Ciccarelli R., Di Iorio P. Caciagli F. (1999) Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59, 663 690.
33. Sajadi A., Schneider B. L. Aebischer P. (2004) Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr. Biol. 14, 326 330.
34. Samsam M., Mi W., Wessig C., Zielasek J., Toyka K. V., Coleman M. P. Martini R. (2003) The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J. Neurosci. 23, 2833 2839.
35. Sasaki Y., Araki T. Milbrandt J. (2006) Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 26, 8484 8491.
36. +. J. Neurosci. (In press).
37. Sawynok J. Liu X. J. (2003) Adenosine in the spinal cord and periphery: release and regulation of pain. Prog. Neurobiol. 69, 313 340.
38. Saxena S. Caroni P. (2007) Mechanisms of axon degeneration: from development to disease. Prog. Neurobiol. 83, 174 191.
39. Snyder S. H. (1985) Adenosine as a neuromodulator. Annu. Rev. Neurosci. 8, 103 124.
40. Stone T. W., Forrest C. M., Mackay G. M., Stoy N. Darlington L. G. (2007) Tryptophan, adenosine, neurodegeneration and neuroprotection. Metab. Brain Dis. 22, 337 352.
41. Wakade A. R., Przywara D. A. Wakade T. D. (2001) Intracellular, nonreceptor-mediated signaling by adenosine: induction and prevention of neuronal apoptosis. Mol. Neurobiol. 23, 137 153.
42. Wang M. S., Davis A. A., Culver D. G. Glass J. D. (2002) WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann. Neurol. 52, 442 447.
43. Wang J., Zhai Q., Chen Y., Lin E., Gu W., McBurney M. W. He Z. (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell Biol. 170, 349 355.